Choosing A CDMO For Oral Solids, Nasal And Pulmonary Dosage Forms: Capabilities Overview

Gain valuable insights into selecting the right Contract Development and Manufacturing Organization (CDMO) for oral solids, nasal, and pulmonary dosage forms in this informative webinar led by Chief Technical Officer Ian Lafferty.

Learn about UK-based Upperton Pharma Solutions and the many advantages of partnering with a CDMO, including their extensive expertise and capabilities across oral solids and specialized nasal and pulmonary formulations. The webinar will also cover Upperton's state-of-the-art GMP manufacturing facilities, robust research and development capabilities, and comprehensive QC and analytical services, highlighting their commitment to delivering high-quality pharmaceutical solutions.